These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7771889)

  • 21. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
    Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
    Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Percutaneous revascularization of multivessel coronary disease with systematic stent implantation. Immediate results and clinical follow-up and middle term angiography].
    Chassaing S; Eltchaninoff H; Koning R; Cribier A
    Arch Mal Coeur Vaiss; 2001 Feb; 94(2):95-102. PubMed ID: 11265559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting.
    Barragan P; Sainsous J; Silvestri M; Bouvier JL; Comet B; Siméoni JB; Charmasson C; Bremondy M
    Cathet Cardiovasc Diagn; 1994 Jun; 32(2):133-8. PubMed ID: 8062368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silicon carbide-coated stents: clinical experience in coronary lesions with increased thrombotic risk.
    Heublein B; Ozbek C; Pethig K
    J Endovasc Surg; 1998 Feb; 5(1):32-6. PubMed ID: 9497204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary stenting without coumadin: one month results of a French multicenter study.
    Morice MC; Zemour G; Benveniste E; Biron Y; Bourdonnec C; Faivre R; Fajadet J; Gaspard P; Glatt B; Joly P
    Cathet Cardiovasc Diagn; 1995 May; 35(1):1-7. PubMed ID: 7614535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of thrombotic occlusion of coronary stents to the indication for stenting, stent size, and anticoagulation.
    Rozenman Y; Lotan C; Mosseri M; Gotsman MS
    Am J Cardiol; 1995 Jan; 75(1):84-5. PubMed ID: 7801874
    [No Abstract]   [Full Text] [Related]  

  • 28. The importance of adequate anticoagulation to prevent early thrombosis after stenting of stenosed venous bypass grafts.
    Bucx JJ; de Scheerder I; Beatt K; van den Brand M; Suryapranata H; de Feyter PJ; Serruys PW
    Am Heart J; 1991 May; 121(5):1389-96. PubMed ID: 2017971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and mechanisms of action of ticlopidine: a drug useful in maintaining aortocoronary bypass patency].
    Binaghi F; Fronteddu PF; Cannas F; Martelli V
    Minerva Cardioangiol; 1987 Mar; 35(3):117-21. PubMed ID: 2953992
    [No Abstract]   [Full Text] [Related]  

  • 30. PREvention of late Stent Thrombosis by an Interdisciplinary Global European effort: PRESTIGE.
    ; Adriaenssens T; Byrne R
    Eur Heart J; 2014 Aug; 35(32):2128-9. PubMed ID: 25289392
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results in peripheral arterial revascularization with the use of various antiaggregating substances].
    Garrido García H; Rivas Marín J; Vilaplana Serrano F; Martín Infante A
    Rev Clin Esp; 1984 May; 173(4):231-4. PubMed ID: 6207564
    [No Abstract]   [Full Text] [Related]  

  • 32. [Intracoronary endoprostheses (stents). Literature review and local experience].
    Materne P; Vanderperren O; Pourbaix S; Vandormael M; Chevolet C; Boland J
    Rev Med Liege; 1991 Oct; 46(10):520-8. PubMed ID: 1957070
    [No Abstract]   [Full Text] [Related]  

  • 33. Prothrombin fragments and thrombotic occlusion of coronary stents.
    Swars H; Hafner G; Erbel R; Ehrenthal W; Rupprecht HJ; Prellwitz W; Meyer J
    Lancet; 1991 Jan; 337(8732):59-60. PubMed ID: 1670686
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversing risk in coronary disease.
    Horton R
    Lancet; 1994 Nov; 344(8935):1497-8. PubMed ID: 7968128
    [No Abstract]   [Full Text] [Related]  

  • 35. Ticlopidine versus oral anticoagulation for coronary stenting.
    Cosmi B; Rubboli A; Castelvetri C; Milandri M
    Cochrane Database Syst Rev; 2001; 2001(4):CD002133. PubMed ID: 11687144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pilot study of the efficacy of ticlopidine in early patency of coronary endoprostheses].
    Barragan P; Sainsous J; Silvestri M; Bouvier JL; Comet B; Siméoni JB; Villain P; Pietri P; Quatre JM; Bayet G
    Arch Mal Coeur Vaiss; 1994 Nov; 87(11):1431-7. PubMed ID: 7771889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of heparin-coated stent in early setting of acute myocardial infarction.
    Shin EK; Son JW; Sohn MS; Jin DK; Park GS; Koh KK; Ahn TH; Choi IS
    Catheter Cardiovasc Interv; 2001 Mar; 52(3):306-12. PubMed ID: 11246241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary stenting in 1000 consecutive patients. Long-term clinical and angiographic results.
    Colombo A; Di Mario C; Reimers B; Blengino S; Akiyama T; Ferraro M; Martini G; Di Francesco L; Finci L
    G Ital Cardiol; 1997 Jan; 27(1):19-31. PubMed ID: 9199940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evolution in coronary stenting: use of ticlopidine with and without oral anticoagulants].
    Zanini R; Bonandi L; Curello S; Bersatti F; Giovannini G; Metra M; Dei Cas L
    Cardiologia; 1997 Aug; 42(8):837-43. PubMed ID: 9312409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.